Entera Bio ENTX
NASDAQ ENTX
$3.02 +0.00 (+0.00%)
As of: Oct 21, 2026 · 2:32 PM EDT

Entera Bio (ENTX) Non-Current Debt (2017 - 2026)

Updated

Entera Bio's Non-Current Debt came in at $284,000 for Q2 2026, down 45.8% from $524,000 a year earlier and down 49.9% from the prior quarter.

Analysis

Entera Bio (ENTX) Non-Current Debt (2017 - 2026) Analysis & Trends

At the end of FY2025, Entera Bio's Non-Current Debt was $393,000.

  • Business Quant data shows ENTX's Non-Current Debt at $567,000 (Q1 2026), $393,000 (Q4 2025) and $527,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn 62.48 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 60.50 Bn
10 Entera Bio 152.36 Mn 121.23 Mn - 284,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 284,000.00
Mar 31, 2026 567,000.00
Dec 31, 2025 393,000.00
Sep 30, 2025 527,000.00
Jun 30, 2025 524,000.00
Mar 31, 2025 515,000.00
Dec 31, 2017 3.89 Mn
API Access

Entera Bio Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENTX&period=max&api_key=YOUR_API_KEY